Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Effects of the Allosteric Antagonist 1-(4-Chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 Receptor Modulation in the Cerebellum

Xiaowei Wang, James G. Horswill, Benjamin J. Whalley and Gary J. Stephens
Molecular Pharmacology April 2011, 79 (4) 758-767; DOI: https://doi.org/10.1124/mol.110.068197
Xiaowei Wang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James G. Horswill
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin J. Whalley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary J. Stephens
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 79 no. 4 758-767
DOI 
https://doi.org/10.1124/mol.110.068197
PubMed 
21189269

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received August 21, 2010
  • Accepted December 15, 2010
  • Published online March 18, 2011.

Article Versions

  • Earlier version (December 28, 2010 - 04:31).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2011 The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Xiaowei Wang,
  2. James G. Horswill,
  3. Benjamin J. Whalley and
  4. Gary J. Stephens
  1. School of Pharmacy University of Reading, Whiteknights, Reading, United Kingdom (X.W., B.J.W., G.J.S.); and Prosidion Limited, Oxford, United Kingdom (J.G.H.)
  1. Address correspondence to:
    Dr. Gary Stephens, School of Pharmacy, University of Reading, Whiteknights, P.O. Box 228, Reading RG6 6AJ, United Kingdom. E-mail: g.j.stephens{at}reading.ac.uk
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: December 2010 to March 2023

AbstractFullPdf
Dec 201057017
Jan 2011169097
Feb 201151050
Mar 20112581765
Apr 20112341835
May 2011731519
Jun 2011622222
Jul 2011451929
Aug 201135717
Sep 20114184
Oct 20112126
Nov 20112936
Dec 20112027
Jan 201237410
Feb 20122875
Mar 201240814
Apr 2012311017
May 2012431623
Jun 2012191117
Jul 2012201117
Aug 201225610
Sep 2012221518
Oct 2012431423
Nov 201229914
Dec 2012211415
Jan 2013532120
Feb 201320910
Mar 2013211613
Apr 2013341313
May 2013261225
Jun 20132173
Jul 201315414
Aug 2013946
Sep 2013142512
Oct 201338913
Nov 201313719
Dec 2013748
Jan 2014872
Feb 20141745
Mar 201410137
Apr 20142354
May 20141857
Jun 20147105
Jul 201411975
Aug 2014645
Sep 2014773
Oct 20142596
Nov 20142343
Dec 201428435
Jan 2015191222
Feb 2015550
Mar 201519114
Apr 20151553
May 201519146
Jun 20152654
Jul 2015132412
Aug 201516153
Sep 2015860
Oct 2015702
Nov 2015573
Dec 20151134
Jan 20161448
Feb 201613317
Mar 201617415
Apr 201613108
May 2016231818
Jun 20161267
Jul 20161493
Aug 201621117
Sep 2016655
Oct 20164157
Nov 20164145
Dec 20164176
Jan 20170133
Feb 20170194
Mar 201701910
Apr 201701216
May 201701111
Jun 20171136
Jul 20170261
Aug 20171371
Sep 20170144
Oct 20172218
Nov 20174176
Dec 20171153
Jan 20184130
Feb 20180180
Mar 20185226
Apr 20180161
May 20185286
Jun 20180255
Jul 201842012
Aug 20184163
Sep 20181114
Oct 201821312
Nov 201822612
Dec 20181430
Jan 20191000
Feb 20192034
Mar 20191602
Apr 20191214
May 20191811
Jun 20191137
Jul 20191034
Aug 20191321
Sep 20191625
Oct 20191034
Nov 20192162
Dec 20191613
Jan 2020911
Feb 2020701
Mar 2020801
Apr 2020800
May 2020632
Jun 20201323
Jul 20201333
Aug 2020802
Sep 2020800
Oct 2020703
Nov 2020634
Dec 20201600
Jan 20211234
Feb 20211854
Mar 20211325
Apr 2021610
May 20214342
Jun 20211410
Jul 20211223
Aug 2021723
Sep 20211211
Oct 20211320
Nov 2021534
Dec 20212821
Jan 20222110
Feb 20221912
Mar 20222411
Apr 20221410
May 2022710
Jun 20221912
Jul 20221013
Aug 20221441
Sep 2022611
Oct 20221212
Nov 20221721
Dec 20221301
Jan 2023813
Feb 20231221
Mar 20231323

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 79 (4)
Molecular Pharmacology
Vol. 79, Issue 4
1 Apr 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Effects of the Allosteric Antagonist 1-(4-Chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 Receptor Modulation in the Cerebellum
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Effects of the Allosteric Antagonist 1-(4-Chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 Receptor Modulation in the Cerebellum

Xiaowei Wang, James G. Horswill, Benjamin J. Whalley and Gary J. Stephens
Molecular Pharmacology April 1, 2011, 79 (4) 758-767; DOI: https://doi.org/10.1124/mol.110.068197

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Effects of the Allosteric Antagonist 1-(4-Chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 Receptor Modulation in the Cerebellum

Xiaowei Wang, James G. Horswill, Benjamin J. Whalley and Gary J. Stephens
Molecular Pharmacology April 1, 2011, 79 (4) 758-767; DOI: https://doi.org/10.1124/mol.110.068197
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Mechanism of the selective action of paraherquamide A
  • Fatty Acid Amide Hydrolase in Cisplatin Nephrotoxicity
  • Use-Dependent Relief of A-887826 Inhibition
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics